Abstract:<span class="a-plus-plus abstract-section id-a-sec1"><h3 class="a-plus-plus">Purpose</h3><p class="a-plus-plus">The 2019 novel coronavirus (COVID-19) is an emerging pandemic, with a disease course varying from asymptomatic infection to critical disease resulting to death. Recognition of prognostic factors is essential because of its growing prevalence and high clinical costs. This meta-analysis aimed to evaluate the global prevalence of obesity in COVID-19 patients and to investigate whether obesity is a risk factor for the COVID-19, COVID-19 severity, and its poor clinical outcomes including hospitalization, intensive care unit (ICU) admission, need for mechanical ventilation, and mortality.</p></span><span class="a-plus-plus abstract-section id-a-sec2"><h3 class="a-plus-plus">Methods</h3><p class="a-plus-plus">The study protocol was registered in PROSPERO (CRD42020203386). A systematic search of Scopus, Medline, and Web of Sciences was conducted from 31 December 2019 to 1 June 2020 to find pertinent studies. After selection, 54 studies from 10 different countries were included in the quantitative analyses. Pooled odds ratios (OR) with 95% confidence intervals (CIs) were calculated to assess the associations.</p></span><span class="a-plus-plus abstract-section id-a-sec3"><h3 class="a-plus-plus">Results</h3><p class="a-plus-plus">The prevalence of obesity was 33% (95% CI 30.0%–35.0%) among patients with COVID-19. Obesity was significantly associated with susceptibility to COVID-19 (OR = 2.42, 95% CI 1.58–3.70; moderate certainty) and COVID-19 severity (OR = 1.62, 95% CI 1.48–1.76; low certainty). Furthermore, obesity was a significant risk factor for hospitalization (OR = 1.75, 95% CI 1.47–2.09; very low certainty), mechanical ventilation (OR = 2.24, 95% CI 1.70–2.94; low certainty), intensive care unit (ICU) admission (OR = 1.75, 95% CI 1.38–2.22; low certainty), and death (OR = 1.23, 95% CI 1.06–1.41; low certainty) in COVID-19 patients. In the subgroup analyses, these associations were supported by the majority of subgroups.</p></span><span class="a-plus-plus abstract-section id-a-sec4"><h3 class="a-plus-plus">Conclusion</h3><p class="a-plus-plus">Obesity is associated with COVID-19, need for hospitalization, mechanical ventilation, ICU admission, and death due to COVID-19.</p></span><span class="a-plus-plus abstract-section id-a-sec5"><h3 class="a-plus-plus">Level of evidence</h3><p class="a-plus-plus">Level I, systematic reviews and meta-analyses.</p></span>

&Lt;p>covid-19 and Obesity: Epidemiology, Pathogenesis and Treatment</p>

Obesity is Associated with Increased Severity of Disease in COVID-19 Pneumonia: a Systematic Review and Meta-Analysis

Obesity and COVID-19 Pandemics: Epidemiology, Mechanisms, and Management

Obesity pandemic during COVID-19 outbreak: Narrative review and future considerations

Obesity aggravates COVID-19: An updated systematic review and meta-analysis

Individuals with obesity and COVID‐19: A global perspective on the epidemiology and biological relationships

Obesity population at risk of COVID-19 complications

Obesity is a potential risk factor contributing to clinical manifestations of COVID-19

Understanding the Co-Epidemic of Obesity and COVID-19: Current Evidence, Comparison with Previous Epidemics, Mechanisms, and Preventive and Therapeutic Perspectives

Obesity and COVID-19: Molecular Mechanisms Linking Both Pandemics

Increased COVID-19 Infection Susceptibility and Adverse Outcomes Due to Obesity: A Systematic Review and Meta-analysis

Obesity Increases the Severity and Mortality of Influenza and COVID-19: A Systematic Review and Meta-Analysis

Obesity as a predictor for a poor prognosis of COVID-19: A systematic review

Effects of obesity on patients with COVID-19

Overweight and Obesity are Risk Factors of Severe Illness in Patients with COVID‐19

The Association between Obesity and Severity in Patients with Coronavirus Disease 2019: a Retrospective, Single-center Study, Wuhan

A critical review of health and financial implications of obesity during the COVID-19 pandemic

The negative impact of obesity on the occurrence and prognosis of the 2019 novel coronavirus (COVID-19) disease: a systematic review and meta-analysis

Obesity as a risk factor for COVID-19: an overview

Obesity and its Relationship with Covid-19: A Review of the Main Pharmaceutical Aspects

Obesity is Associated with Severe Forms of COVID‐19

&Lt;p&gt;covid-19 and Obesity: Epidemiology, Pathogenesis and Treatment&lt;/p&gt;